TRDA — ENTRADA THERAPEUTICS INC

Ownership history in StepStone Group LP  ·  17 quarters on record

This page tracks every 13F SEC filing in which StepStone Group LP reported a position in ENTRADA THERAPEUTICS INC (TRDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
11.51% (2024 Q4)
Avg. % of fund
3.41%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 761,277 — 0% 4.19% $7.8M $10.28
2025 Q3 UNCHANGED 761,277 — 0% 2.08% $4.4M $5.80
2025 Q2 UNCHANGED 761,277 — 0% 10.14% $5.1M $6.72
2025 Q1 UNCHANGED 761,277 — 0% 7.07% $6.9M $9.04
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TRDA price (monthly, adj. close)

Other funds also holding TRDA

As of 2025 Q4 — sorted by position size

5AM Venture Management, LLC 3Y 13.11% TCG Crossover Management, LLC 3Y 0.71% Nan Fung Group Holdings Ltd 3Y 0.45% BAKER BROS. ADVISORS LP 3Y 7Y 0.31% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.22% Lynx1 Capital Management LP 3Y 0.11% Dynamic Technology Lab Private Ltd 3Y 7Y 0.06% XTX Topco Ltd 3Y 0.03% ROYCE & ASSOCIATES LP 3Y 7Y 0.03% AXQ CAPITAL, LP 3Y 0.02%
← Back to StepStone Group LP Holdings